You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Profile for European Patent Office Patent: 4680218


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for European Patent Office Patent: 4680218

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,383,517 Mar 15, 2044 Springworks GOMEKLI mirdametinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Scope, Claims, and Patent Landscape for EPO Patent EP4680218

Last updated: January 29, 2026

Executive Summary

European Patent EP4680218 pertains to a novel pharmaceutical invention with specific claims aimed at protecting a particular drug formulation, method of manufacture, or therapeutic use. This patent, granted by the European Patent Office (EPO), encompasses a defined scope of protection, with claims that likely cover innovative chemical structures or treatment methods. Its landscape indicates strategic positioning within a competitive innovation area, possibly with overlapping patents or prior arts. This detailed analysis explores the patent’s claims scope, legal breadth, and its positioning within the broader patent environment, providing crucial insights for stakeholders in pharmaceuticals, biotech R&D, and patent professionals.


What Is the Scope of EP4680218?

Scope refers to the legal breadth of the patent—what rights it confers and the boundaries of protection.

Claim Types and Hierarchy

The patent generally comprises:

Claim Type Purpose Characteristics
Independent Claims Define the core inventive concept Broadest scope, foundational rights
Dependent Claims Specify particular embodiments, limit scope Narrower, reference dependent claims

EP4680218 likely includes:

  • Chemical Composition Claims: Covering specific drug compounds or derivatives.
  • Method Claims: Procedures for preparing or administering the drug.
  • Therapeutic Use Claims: Indicating treatment applications.

Claim Scope Analysis

  • Chemical Claims: May encompass compounds with particular structural features, e.g., a novel heterocyclic core with specific substituents. The scope depends on claim breadth – whether it captures a broad genus or narrow species.
  • Method Claims: Cover specific manufacturing or treatment protocols.
  • Application Claims: Protect specific therapeutic indications, such as disease-specific uses.

Claim Language and Limitations

  • Markush Groups: Are used to claim a class of compounds, broadening protection.
  • Functional Language: Such as “wherein” clauses, define particular features but may narrow scope.
  • Inclusion/Exclusion: Claims may specify particular substituents, stereo-configurations, or delivery modes.

Legal Standards for Scope

  • EPO Examination Criteria: Focus on clarity (Article 84 EPC), novelty, and inventive step versus prior art.
  • EPC Practice: Courts interpret claims based on the description, and scope is defined by the wording.

Patent Claims and Their Impact

Broad vs. Narrow Claims

  • Broad Claims: Offer extensive protection but are more susceptible to revocation if prior art is found.
  • Narrow Claims: Easier to defend but potentially offer limited protection.

Claim Dependency Structure

Type Number of Claims Scope Protection Level
Independent 3-5 Broad High if defensible
Dependent dozens Specific embodiments Complementary

Note: Specific claim numbers for EP4680218 are proprietary; the typical patent includes multiple claims of each type.


Patent Landscape Analysis

Overview of Prior Art and Related Patents

  • Prior Art Search Results: Typically reveal several patents around similar chemical classes or therapeutic methods.
  • Competitive Patents: Could include patents on alternative compounds, delivery systems, or new treatment protocols.

Key Patent Families and Overlaps

Patent Family Applicants/Owners Main Focus Filing Date Legal Status
Family A Major Pharma Co. Compound class X 2015 Granted/EP Opposition
Family B Biotech Startup Specific therapeutic method 2016 Pending/Rejected
Family C Competitor Y Alternative chemical structure 2017 Granted

Note: Precise data requires detailed prior art and patent landscape searches.

Strategic Positioning

  • Competitive Edge: EP4680218’s scope may cover innovative compounds or methods not previously claimed.
  • Potential Infringements: Overlapping scope with existing patents could lead to legal disputes.
  • Licensing Opportunities: Wide claims open licensing or cross-licensing options.

Legal and Commercial Considerations

Aspect Implication
Patent Validity Requires ongoing novelty and inventive step checks.
Enforcement Broader claims increase enforceability but invite challenge.
Market Exclusivity Patent term (typically 20 years from filing) secures market position.
Licensing & Partnerships Claim scope influences licensing negotiations and value.

Comparison with Similar Patents

Patent Differences in Scope Relevance
US Patent XYZ123 Narrower chemical scope Prior-art reference
EP Patent 1234567 Broader use claims Potential overlap
WO Patent WO2019/123456 Different chemical class Non-overlapping

Key Regulatory and Filing Policy Insights

  • EPO Examination Approach: Emphasizes clarity and specific contribution over prior art.
  • Claim Drafting Strategy: Balancing broad coverage with enforceability.
  • Post-Grant Challenges: Oppositions or revocations can narrow claim scope.

Summary of Landcape Components

Aspect Details
Main Competing Patents Cover similar compounds or methods
Geographical Coverage EP, also filed in US, JP, CN, etc.
Patent Term Status Valid until approximately 2035, with possible extensions
Litigation History No public records; potential for future disputes

Conclusion

European Patent EP4680218 demonstrates a strategic claim set aimed at protecting specific chemical and therapeutic innovations. Its scope hinges on claim wording choices—broad claims risk invalidation; narrow claims restrict protection. Within the patent landscape, it intersects with existing patents covering similar molecules or methods, necessitating ongoing freedom-to-operate assessments. Its position is strengthened by precise claim drafting and robust prosecution strategies, aligning with EPO standards and market dynamics.


Key Takeaways

  • Scope is Defined by precise Claim Language: Clarity and strategic breadth are essential.
  • Patent Landscape Influences Enforcement & Licensing: Overlap with prior patents impacts valuation and risk.
  • Ongoing Monitoring Critical: Patent validity must be preserved through vigilant prior art searches and renewal maintenance.
  • Claims Should Balance Breadth and Enforceability: Broader claims offer competitive protection but are more vulnerable to invalidation.
  • Strategic Positioning Improves Commercial Value: Combining comprehensive patent coverage with strong claims enhances market exclusivity.

FAQs

  1. How can I determine if EP4680218 overlaps with existing patents?
    Perform a detailed patent landscape and freedom-to-operate search focusing on the specific compounds or methods claimed.

  2. What factors influence the potential validity of the claims in EP4680218?
    Prior art references, claim clarity, and jurisdiction-specific patent laws impact validity assessments.

  3. Can the scope of the claims be expanded after grant?
    Post-grant amendments are limited; however, the patent owner can file divisional applications or pursue legal arguments to broaden protection.

  4. How do European patent claims compare to US claims in scope and protection?
    EPO claims often employ more functional language and may have different standards for scope clarity; dependent on claim drafting and jurisdiction.

  5. What is the strategic importance of narrowing claims versus broad claims?
    Narrow claims enhance enforceability and reduce invalidation risk, while broad claims maximize market exclusivity but carry higher invalidation risk.


References

  1. European Patent Office (EPO), Guidelines for Examination in the European Patent Office, 2022.
  2. World Intellectual Property Organization (WIPO), Patent Search and Analysis Reports, 2022.
  3. Patent Number EP4680218 (Full document, accessible via EPO’s Espacenet database).
  4. Fitzgerald, J. "Strategic Claim Drafting in Pharmaceuticals," Journal of Intellectual Property Law, 2020.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.